The Drug Enforcement Administration has dismantled a laboratory in Louisiana that CBS News described as the first nitazene synthesis lab in the United States. CBS News reported the action under a headline stating that the agency had dismantled the facility.
According to CBS News, forensic testing by the DEA confirmed that the lab was manufacturing etonitazene. The outlet described etonitazene as an extremely potent synthetic opioid.
CBS News said etonitazene belongs to a class of drugs known as nitazenes. The outlet's summary connects the laboratory finding to that class, but it does not describe the effects of nitazenes or how they are typically used.
The CBS News headline and summary together describe two points: that the site was dismantled, and that forensic testing identified the substance being made there. Those two points are the basis of the account in this report.
The material available for this report did not include details about the size of the lab, its operators, any arrests, the amount of material found, or where the drugs were intended to go. The CBS News headline and summary do not address those points, and this report does not supply them.
Because only the CBS News headline and summary were available, the account rests on that single outlet. No other news organization's reporting on the Louisiana lab was reviewed for this story, and the material provided did not include a direct statement from the DEA.
Sources: CBS News: DEA dismantles first nitazene synthesis lab in the U.S..